egtazic acid has been researched along with Anterior Cerebral Circulation Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartnik, BL; Obenaus, A; Spigelman, I | 1 |
| Bornstein, NM; Diener, HC; Kozak, A; Lampl, Y; Rosenberg, G; Schneider, D | 1 |
1 trial(s) available for egtazic acid and Anterior Cerebral Circulation Infarction
| Article | Year |
|---|---|
DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.
Topics: Acute Disease; Aged; Aged, 80 and over; Brain; Brain Infarction; Brain Ischemia; Cell Membrane; Chelating Agents; Cytoprotection; Double-Blind Method; Egtazic Acid; Emergency Medical Services; Female; Humans; Injections, Intravenous; Ions; Male; Metals; Middle Aged; Neuroprotective Agents; Placebos; Treatment Outcome | 2008 |
1 other study(ies) available for egtazic acid and Anterior Cerebral Circulation Infarction
| Article | Year |
|---|---|
Cell-permeant calcium buffer induced neuroprotection after cortical devascularization.
Topics: Animals; Brain Infarction; Brain Injuries; Brain Mapping; Cell Count; Cerebral Cortex; Chelating Agents; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Ectodysplasins; Egtazic Acid; Glial Fibrillary Acidic Protein; Histological Techniques; Immunohistochemistry; Male; Membrane Proteins; Phagocytes; Rats; Rats, Wistar; Time Factors | 2005 |